Загрузка...
A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars
Ocular and urogenital infections with Chlamydia trachomatis (C.t.) are caused by a range of different serovars. The first C.t. vaccine in clinical development (CTH522/CAF®01) induced neutralizing antibodies directed to the variable domain 4 (VD4) region of major outer membrane protein (MOMP), coveri...
Сохранить в:
| Опубликовано в: : | NPJ Vaccines |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8055873/ https://ncbi.nlm.nih.gov/pubmed/33875654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-021-00312-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|